| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.vbshilpa.com | |
| Market Cap | 5,227.41 Cr. | |
| Enterprise Value(EV) | 6,066.93 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -0.07 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 40.73 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 234.10 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.28 | Calculated using Price: 534.55 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 9.78 Cr. | 97,790,908 Shares |
| FaceValue | 1 | |
| About Shilpa Medicare Ltd. | ||
| Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications. | ||
| 1 Day |
|
+1.57% |
| 1 Week |
|
+4.33% |
| 1 Month |
|
+16.36% |
| 3 Month |
|
+62.04% |
| 6 Month |
|
+57.99% |
| 1 Year |
|
+111.88% |
| 2 Year |
|
+11.93% |
| 5 Year |
|
+34.00% |
| 10 Year |
|
+148.57% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 15.4 | 17.66 | 12.85 | 9.93 | 9.59 | 12.23 | 10.41 | 3.67 | -1.71 | |
| Return on Capital Employed (%) | 17.9 | 19.69 | 15.28 | 11.13 | 10.45 | 12.38 | 10.73 | 5.94 | 0.8 | |
| Return on Assets (%) | 9.18 | 11.41 | 8.69 | 6.92 | 7.04 | 8.59 | 6.33 | 2.2 | -1.07 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 547 | 639 | 987 | 1,085 | 1,198 | 1,329 | 1,479 | 1,822 | 1,783 | 1,783 | |
| Non Curr. Liab. | 154 | 67 | 251 | 153 | 167 | 257 | 561 | 453 | 345 | 599 | |
| Curr. Liab. | 189 | 222 | 237 | 266 | 253 | 411 | 587 | 612 | 783 | 630 | |
| Minority Int. | 14 | 2 | -3 | -5 | -8 | -8 | -11 | -11 | -9 | -9 | |
| Equity & Liab. | 905 | 931 | 1,472 | 1,499 | 1,610 | 1,989 | 2,632 | 2,876 | 2,902 | 3,004 | |
| Non Curr. Assets | 577 | 577 | 742 | 827 | 1,065 | 1,365 | 1,730 | 1,988 | 2,134 | 2,179 | |
| Curr. Assets | 328 | 354 | 730 | 672 | 545 | 624 | 862 | 887 | 768 | 825 | |
| Misc. Exp. not W/O | 0 | ||||||||||
| Total Assets | 905 | 931 | 1,472 | 1,499 | 1,610 | 1,989 | 2,632 | 2,876 | 2,902 | 3,004 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 614 | 716 | 779 | 789 | 733 | 908 | 901 | 1,146 | 1,050 | 1,123 | |
| Other Income | 7 | 11 | 29 | 33 | 16 | 22 | 40 | 21 | 31 | 8 | |
| Total Income | 621 | 728 | 809 | 821 | 749 | 930 | 941 | 1,166 | 1,082 | 1,131 | |
| Total Expenditure | -487 | -556 | -618 | -638 | -579 | -693 | -729 | -948 | -962 | -911 | |
| PBIDT | 133 | 171 | 191 | 184 | 170 | 237 | 212 | 218 | 120 | 221 | |
| Interest | -4 | -4 | -3 | -3 | -4 | -5 | -22 | -41 | -59 | -85 | |
| Depreciation | -21 | -23 | -31 | -37 | -42 | -44 | -54 | -80 | -96 | -107 | |
| Taxation | -35 | -36 | -42 | -34 | -26 | -33 | -49 | -42 | 7 | -23 | |
| Exceptional Items | 0 | -2 | -5 | 20 | 61 | 9 | |||||
| PAT | 73 | 105 | 104 | 103 | 110 | 155 | 146 | 61 | -31 | 5 | |
| Minority Interest | 1 | 4 | 3 | 2 | 3 | 2 | 2 | 0 | -2 | 0 | |
| Share Associate | -6 | ||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 74 | 108 | 108 | 105 | 112 | 156 | 148 | 61 | -32 | -1 | |
| Adjusted EPS | 10 | 14 | 13 | 13 | 14 | 19 | 18 | 7 | -4 | 0 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 70 | 69 | 129 | 37 | 45 | 147 | 124 | 47 | 105 | 226 | |
| Cash Fr. Inv. | -49 | -195 | -109 | -262 | -9 | -196 | -290 | -404 | -286 | -278 | |
| Cash Fr. Finan. | -28 | 136 | -20 | 313 | -61 | 10 | 176 | 436 | 83 | 46 | |
| Net Change | -7 | 10 | 0 | 88 | -25 | -39 | 10 | 79 | -98 | -7 | |
| Cash & Cash Eqvt | 9 | 18 | 6 | 100 | 74 | 34 | 44 | 123 | 25 | 19 |
|
Fri, 19 Apr 2024
Compliance Certificate For The Period Ending March 31 2024. Pursuant to Regulation 7(3) of SEBI (LODR) Regulations 2015 please find enclosed a certificate dated April 18 2024 for the year ending March 31 2024. Certifying that all activities in relation to both physical and electronic share transfer facilities were maintained by "M/s Kfin Technologies Limited" (SEBI Registration No. INR000000221) the Registrar and Share Transfer Agent of Shilpa Medicare Limited. |
|
Fri, 19 Apr 2024
Compliance Certificate Under Regulation 40(10) SEBI (LODR) Regulations 2015. Pursuant to Regulation 40(9) of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the certificate dated April 19 2024 for the year ending March 31 2024 issued by CS D S Rao Practicing Company Secretary CP No. 14487. |
|
Fri, 19 Apr 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shilpa Medicare Ltd QIP |
| Fri, 19 Apr 2024 |
Close Within 52 Week High Zone
|
High Increase in 1 Month
|
High Increase in 3 Months
|
High Increase in 6 Months
|
High Increase in 1 Year
|
